Madrid tenders works for new neurorehabilitation center at Zendal

The Community of Madrid will invest 6 million euros in the construction of this healthcare facility, located at the Enfermera Isabel Zendal Hospital, to serve over a thousand people annually.

Generic image of a modern hospital facade.
IA

Generic image of a modern hospital facade.

The Community of Madrid has approved the tender for the construction of a new Neurorehabilitation Center at the Enfermera Isabel Zendal Hospital, with an investment of 6 million euros, aiming to consolidate the complex as a reference in cerebral and neurological pathologies.

This new resource, announced during the 2024 Debate on the State of the Region, will be located in Pavilion 1 of the Valdebebas health complex. Adaptation works are expected to last six months, with the goal of the center becoming operational by early 2027.
The future center will have the capacity to treat 1,123 people each year, offering 216 places and performing 596 daily therapies. It will provide assistance to adult and pediatric patients with brain and spinal cord injuries through multidisciplinary treatments including Physiotherapy, Speech Therapy, Occupational Therapy, and other associated specialties.

"The center will operate under a day care model to encourage the participation and involvement of families and caregivers during the rehabilitation process."

the regional government
This initiative seeks to strengthen the role of the Enfermera Isabel Zendal Public Hospital as a reference center for cerebral and neurological pathologies. The complex already houses the Specialized Day Care Center for people with Amyotrophic Lateral Sclerosis (CEADELA), which has been operational since April 2024.
Additionally, the regional Executive is working on incorporating an Experimental Institute of Neurotechnology for Brain Health into Zendal, along with cutting-edge devices for research and diagnosis of neurodegenerative diseases. This includes very high-field magnetic resonances and technology based on biomedical engineering and Artificial Intelligence, to improve early detection and care for patients with conditions such as dementia, Parkinson's, or Alzheimer's.